Day: March 24, 2026

Innovating access across complex generics, biosciences, and specialty medicines For over 20 years, we’ve pushed the limits of what’s possible to make advanced medicines accessible to more people. Today, our portfolio spans 290+ high-quality pharmaceuticals, powered by new operational advances and an exceptionally skilled team.